Keensight Capital-backed Inke, a Spain-based global manufacturer of inhalation APIs and Highly Potent APIs (HPAPIs), has acquired Pharmanoid, a manufacturing site specialising in the production of HPAPIs for ophthalmology, from Gentec Pharmaceutical Group.
The acquisition broadens Inke’s portfolio beyond respiratory APIs and “marks a significant step in solidifying Inke’s position...
MML Capital Partners has announced the final close of MML Keystone I and accompanying co-investment and managed vehicles, raising €935m (US$1.1bn).
“Raising over €900m for a first-time strategy is a strong endorsement of both the team and the Keystone investment approach,” said Andrew Honan, co-managing partner.
Commitments were secured from a globally diverse group of blue-chip institutional investors including pension funds, consultants, asset managers, funds of funds and family offices from Europe, North America, Asia, Australia and the Middle East.
MML Keystone I caps off a successful year for MML during which...
